A citation-based method for searching scientific literature

Thomas Fremming Dejgaard, Christian Seerup Frandsen, Tanja Stenbæk Hansen, Thomas Almdal, Søren Urhammer, Ulrik Pedersen-Bjergaard, Tonny Jensen, Andreas Kryger Jensen, Jens Juul Holst, Lise Tarnow, Filip Krag Knop, Sten Madsbad, Henrik Ullits Andersen. Lancet Diabetes Endocrinol 2016
Times Cited: 67



Christian S Frandsen, Thomas F Dejgaard, Jens J Holst, Henrik U Andersen, Birger Thorsteinsson, Sten Madsbad. Diabetes Care 2015
Times Cited: 50




List of shared articles



Times cited


Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial.
Thomas F Dejgaard, Signe Schmidt, Christian S Frandsen, Dorte Vistisen, Sten Madsbad, Henrik U Andersen, Kirsten Nørgaard. Diabetes Obes Metab 2020
5

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.
Chantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, Vincent Woo, Peter Colman, Erik Christiansen, Martin Linder, Bruce Bode. Diabetes Care 2016
95


Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?
Harriet Warnes, Rebecca Helliwell, Sam Matthew Pearson, Ramzi A Ajjan. Diabetes Ther 2018
9

Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes.
Sara E Lingow, Sandra D Burke, Amie D Brooks, Pat S Rafferty. Diabetes Spectr 2019
0

Incretin-based therapies for patients with type 1 diabetes: a meta-analysis.
Lili Liu, Zhuo Shao, Ying Xia, Jiabi Qin, Yang Xiao, Zhiguang Zhou, Zubing Mei. Endocr Connect 2019
6

Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.
Nicklas Järvelä Johansen, Thomas Fremming Dejgaard, Asger Lund, Tina Vilsbøll, Henrik Ullits Andersen, Filip Krag Knop. BMJ Open 2018
2

Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis.
Patoulias Dimitrios, Doumas Michael, Kotsis Vasilios, Stavropoulos Konstantinos, Imprialos Konstantinos, Zografou Ioanna, Petidis Konstantinos, Bakatselos Spyridon, Karagiannis Asterios. Curr Diabetes Rev 2020
11


Glycemic Management in Adults With Type 1 Diabetes.
Angela McGibbon, Lenley Adams, Karen Ingersoll, Tina Kader, Barna Tugwell. Can J Diabetes 2018
11

New Frontiers in the Treatment of Type 1 Diabetes.
Jeremy T Warshauer, Jeffrey A Bluestone, Mark S Anderson. Cell Metab 2020
21

Adjunctive therapy for glucose control in patients with type 1 diabetes.
Kira Harris, Cassie Boland, Lisa Meade, Dawn Battise. Diabetes Metab Syndr Obes 2018
8

Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes.
Thomas F Dejgaard, Nanna B Johansen, Christian S Frandsen, Ali Asmar, Lise Tarnow, Filip K Knop, Sten Madsbad, Henrik U Andersen. Diabetes Obes Metab 2017
9

Double Diabetes: A Growing Problem Requiring Solutions.
Djordje S Popovic, Nikolaos Papanas. Exp Clin Endocrinol Diabetes 2021
0

Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial.
Nicklas J Johansen, Thomas F Dejgaard, Asger Lund, Camilla Schlüntz, Emil L Larsen, Henrik E Poulsen, Jens P Goetze, Holger J Møller, Tina Vilsbøll, Henrik U Andersen,[...]. Diabetes Obes Metab 2020
0

Involvement of TGF-β and Autophagy Pathways in Pathogenesis of Diabetes: A Comprehensive Review on Biological and Pharmacological Insights.
Fatemeh Heydarpour, Soraya Sajadimajd, Elahe Mirzarazi, Pouya Haratipour, Tanuj Joshi, Mohammad Hosein Farzaei, Haroon Khan, Javier Echeverría. Front Pharmacol 2020
2


Efficacy and safety of incretin-based drugs in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
Wen Wang, Yun Gao, Dawei Chen, Chun Wang, Xiaobing Feng, Xingwu Ran. Diabetes Res Clin Pract 2017
6


Current and future therapies for type 1 diabetes.
Bernt Johan von Scholten, Frederik F Kreiner, Stephen C L Gough, Matthias von Herrath. Diabetologia 2021
2

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
Julia K Mader, Lene Jensen, Steen H Ingwersen, Erik Christiansen, Simon Heller, Thomas R Pieber. Clin Pharmacokinet 2016
6

Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial.
Anne-Marie Langmach Wegeberg, Christian Stevns Hansen, Adam D Farmer, Jesper Scott Karmisholt, Asbjorn M Drewes, Poul Erik Jakobsen, Birgitte Brock, Christina Brock. United European Gastroenterol J 2020
0

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials.
Xu Zhao, Kun Huang, Meijie Zheng, Junting Duan. BMC Endocr Disord 2019
10


Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.
Nitesh D Kuhadiya, Ben Prohaska, Husam Ghanim, Paresh Dandona. Diabetes Obes Metab 2019
1

Liraglutide for treating type 1 diabetes.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Jens Juul Holst, Sten Madsbad. Expert Opin Biol Ther 2016
8


Adjunct therapies in treatment of type 1 diabetes.
Itivrita Goyal, Alamgir Sattar, Megan Johnson, Paresh Dandona. J Diabetes 2020
2

Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
Justinne Guyton, Michelle Jeon, Amie Brooks. Am J Health Syst Pharm 2019
0


The impact of pharmacological and lifestyle interventions on body weight in people with type 1 diabetes: A systematic review and meta-analysis.
Saniya Tandon, Salma Ayis, David Hopkins, Seeromanie Harding, Marietta Stadler. Diabetes Obes Metab 2021
1

Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes.
Mustafa Tosur, Maria J Redondo, Sarah K Lyons. Curr Diab Rep 2018
4

GLP-1 Agonists in Type 1 Diabetes Mellitus.
Kristin M Janzen, Taylor D Steuber, Sarah A Nisly. Ann Pharmacother 2016
15

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.
Nitesh D Kuhadiya, Sandeep Dhindsa, Husam Ghanim, Aditya Mehta, Antoine Makdissi, Manav Batra, Sartaj Sandhu, Jeanne Hejna, Kelly Green, Natalie Bellini,[...]. Diabetes Care 2016
43

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial.
Bo Ahrén, Irl B Hirsch, Thomas R Pieber, Chantal Mathieu, Fernando Gómez-Peralta, Troels Krarup Hansen, Areti Philotheou, Sune Birch, Erik Christiansen, Thomas Jon Jensen,[...]. Diabetes Care 2016
68